GGrantIndex
← Leaderboards

Leslie Philip Weiner

University Of Southern California

$6,552,756
Attributed
$6,552,756
Total exposure
5
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $752.3K · FY200506
$1M$750K$500K$250K$0
'05
'06

Funding mix

By agency

NIH$6,552,756 · 5

By mechanism

R01$3,977,843 · 1
M01$1,697,127 · 2
K12$479,248 · 1
P01$398,538 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Southern California

Same institution · by research overlap

Others in their field

Top investigators on “T Lymphocyte

Research focus

T LymphocyteMultiple SclerosisHuman SubjectClinical ResearchHuman Therapy EvaluationVaccinesMagnetic Resonance ImagingImmunotherapyCytokineMyelinClinical Trial Phase IImmunopathology TherapyVaccine DevelopmentLeukocyte Activation /TransformationCellular ImmunityNervous System Disorder ChemotherapyCell TransplantationPathologic ProcessClinical Trial Phase IiMonoclonal AntibodyImmunocytochemistryAntigen Antibody ReactionHybridomasHelper T Lymphocyte

Grant awards (22)

T CELL VACCINATION: A CLINICAL TRIAL FOR SECONDARY PROGRESSIVE MS$29,395
M01 · FY2006 · RR · contact PI
T-Cell Vaccine-A Clinical Trail for Progressive MS$545,659
R01 · FY2005 · NS
T CELL VACCINATION: A CLINICAL TRIAL FOR SECONDARY PROGRESSIVE MS$206,593
M01 · FY2005 · RR
T Cell Vaccination: A Clinical Trial for MS$1,269,822
M01 · FY2004 · RR
T-Cell Vaccine-A Clinical Trail for Progressive MS$658,481
R01 · FY2004 · NS
T-Cell Vaccine-A Clinical Trail for Progressive MS$975,900
R01 · FY2003 · NS
T CELL VACCINE--A CLINICAL TRIAL FOR PROGRESSIVE MS$388,797
R01 · FY2002 · NS
CORE--NEUROPATHOLOGY FACILITY$106,204
P01 · FY2002 · NS
T CELL VACCINE--A CLINICAL TRIAL FOR PROGRESSIVE MS$82,500
R01 · FY2002 · NS
T CELL VACCINATION IN MULTIPLE SCLEROSIS--PHASE I CLINICAL TRIAL$0
M01 · FY2002 · RR
T CELL VACCINE--A CLINICAL TRIAL FOR PROGRESSIVE MS$604,010
R01 · FY2001 · NS
T CELL VACCINATION IN MULTIPLE SCLEROSIS--PHASE I CLINICAL TRIAL$155,764
M01 · FY2001 · RR
CORE--NEUROPATHOLOGY FACILITY$106,204
P01 · FY2001 · NS
T CELL VACCINE--A CLINICAL TRIAL FOR PROGRESSIVE MS$81,368
R01 · FY2001 · NS
T CELL VACCINATION IN MULTIPLE SCLEROSIS--PHASE I CLINICAL TRIAL$0
M01 · FY2001 · RR
T CELL VACCINE--A CLINICAL TRIAL FOR PROGRESSIVE MS$641,128
R01 · FY2000 · NS
MCSDPA--NEUROGERONTOLOGY$479,248
K12 · FY2000 · AG
CORE--NEUROPATHOLOGY FACILITY$186,130
P01 · FY2000 · NS
T CELL VACCINATION IN MULTIPLE SCLEROSIS--PHASE I CLINICAL TRIAL$35,553
M01 · FY2000 · RR
T CELL VACCINATION: CLINICAL TRIAL FOR SECONDARY MS$0
M01 · FY2000 · RR
T CELL VACCINATION IN MULTIPLE SCLEROSIS--PHASE I CLINICAL TRIAL$0
M01 · FY2000 · RR
T CELL VACCINATION: CLINICAL TRIAL FOR SECONDARY MS$0
M01 · FY2000 · RR